Randomized Clinical Trial of Rib Fixation Versus Medical Analgesia in Uncomplicated Rib Fractures on Pain Control. (PAROS)

January 16, 2025 updated by: Benoît Bédat

Comparison of Rib Fixation with Medical Analgesia in Patients with Uncomplicated Rib Fractures on Pain Control: a Multi-center Randomized Clinical Trial

Uncomplicated costal fractures often result in persistent pain over the long term. Indeed, cohort studies showed that at 6 months, 22% of patients still had pain and 56% had functional disability. The impact of costal fractures on quality of life is underestimated. The socio-psycho-economic consequences are substantial.

Previous studies have shown that an important factor for persistent pain and functional disability is the intensity of the initial pain. However, preliminary studies have shown promising results with surgical fixation of rib fractures: reduced need for analgesic drugs, reduced pain at 1 month, reduced complications and improved motor skills in patients over 65 years of age.

To date, the only clinical trials that exist focused on the fixation of complicated rib dislocations. While fixation of uncomplicated rib fractures is a common practice, no randomized studies have been conducted to evaluate its impact on pain and quality of life in the medium and long term.

In this context, the aim of our randomized study is to compare pain at 2 months between operated and non-operated patients with uncomplicated rib fractures.

Study Overview

Status

Terminated

Conditions

Detailed Description

Background. Until recently, functional disability and chronic pain and following uncomplicated rib fractures have been scarcely studied. Studies described persistent pain and disability in, respectively, 59% and 76% of patients at two months, and in 22% and 53% of patients at 6 months. In a retrospective study including 216 patients with an isolated thoracic injury, only 34.2% of patients had a good recovery at one year and the six-month return to work rate is of 63%. Persistent pain and disability following rib fractures therefore result in a large psycho-socio-economic impact for health-care system. The only predictive factor for persistent pain and disability is the pain intensity within the first few days after injury. Similarly, the intensity of pain within the first days after thoracotomy predicts long-term post-thoracotomy pain. In a recent meta-analysis, epidural analgesia provides better acute pain relief than intravenous, paravertebral, and intercostal interventions. While meta-analyses conclude that operative fixation of complicated flail chest provide better outcome, the impact of surgery on pain in uncomplicated rib fracture is seldom studied. Some retrospective studies showed promising results of rib fixation with surgery in patients with uncomplicated rib fractures: A study showed that rib fixation reduced postoperative analgesic requirements. Similarly, another study showed that pain was significantly reduced one month after surgery as compared to a non-surgical approach. Finally, it has been recently observed a decreased mortality and respiratory complications after surgery in patients over 65 years old as well as a better functional status at two weeks, two months, and four months.

Trial objectives. No previous studies have provided definitive evidence for recommending rib fixation over simple pain medication to control pain. Our hypothesis is that a surgical approach may have further benefits as compared to a conservative treatment. The primary objective of the study is to compare pain two months after injury between two groups: group 1) patients who are treated with surgery and analgesic treatment; and group 2) patients who are treated with analgesic treatment alone. The secondary objective is to perform a longitudinal analysis over one year of the following parameters: amount of pain medication, quality of life, anxiety and depression, pulmonary capacity, return to work, and adverse events. Financial aspects are also investigated.

Study Type

Interventional

Enrollment (Actual)

102

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Geneva, Switzerland, 1205
        • Unit of Thoracic and Endocrine Surgery, University Hospitals of Geneva

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • At least 2 rib fractures
  • At least 1 dislocated rib fracture
  • Fractures accessible to surgery
  • Thoracic trauma no more than two days prior to screening for inclusion
  • Thoracic epidural analgesia
  • Written informed consent

Exclusion Criteria:

  • Any other concomitant fractures excepted clavicle fracture
  • Respiratory distress syndrome according to the Berlin definition
  • Presence of >1.5 liter of blood drained from the pleural space
  • Hemostasis disorder defined by any of the following criteria:

    • Platelet count < 70'000/mm3,
    • International Normalized Ratio (INR) > 1.2 (Prothrombin < 70%)
    • activated partial thromboplastin time (aPTT) ≥ 60 seconds
    • drugs such as: P2Y12 antagonists (clopidogrel, prasugrel) and glycoprotein IIb/IIIa antagonists (abciximab, tirofiban)
  • Pathological rib fracture due to metastasis
  • Hemodynamic instability: systolic blood pressure < 100 mmHg and heart rate > 100 beats per minute
  • Neurologic disorder: Glasgow Coma Score < 13 in the initial 24 hours, or intracerebral, epidural, subdural, or subarachnoid hemorrhages, or cerebral contusion
  • Titanium allergy
  • Known or suspected non-compliance to medical therapy due to drug or alcohol abuse
  • Age <18 years old
  • Women who know they are pregnant or breast feeding
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Rib fixation (medical devices)
Surgery and pain medication. The pain of patients will be treated with rib fixation and pain medication.

Rib fixation is performed by a senior surgeon. The patient is under general anesthesia. A thoracotomy focused on the fracture is performed to optimize access to the rib to be repaired. Video-assisted thoracic surgery (VATS) can be performed to better localize rib fractures. Significant muscle division is avoided. Removal of the periosteum is not required. The broken rib segments are approximated with forceps and the medical devices are used to fix the fracture. The medical devices are implemented according to the manufacturers' recommendations. The goal is to stabilize the chest wall. It is not useful to fix all fractures to stabilize the wall. A chest tube can be placed at the end of the operation.

Medical devices

The following medical devices can be used:

  • MatrixRIB™, De Puy Synthes Companies, Zuchwill, Switzerland
  • STRATOS™, MedXpert GmbH, Heitersheim, Germany
  • NiTi Fixing PlatesTM, IAWAI, Yandzhou, China
Epidural analgesia is continuing for 24 to 72 hours post-randomization to maximize outcome benefits. Afterwards, paracetamol, NSAID and/or opioid treatment are used according to pain severity. In case of opioid use, morphine treatment is preferred. However, other opioid drugs or doses can be considered to better customize the treatment.
Active Comparator: Pain medication (comparator treatment)
Pain medication only.
Epidural analgesia is continuing for 24 to 72 hours post-randomization to maximize outcome benefits. Afterwards, paracetamol, NSAID and/or opioid treatment are used according to pain severity. In case of opioid use, morphine treatment is preferred. However, other opioid drugs or doses can be considered to better customize the treatment.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain severity
Time Frame: Two months after injury
Pain level reported by the participant, as assessed via the first part of the French version of the brief pain inventory (BPI) questionnaire. 0-10 scale. 10 indicating worst pain
Two months after injury

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain severity
Time Frame: At recruitment (baseline)
Pain level reported by the participant, as assessed via the first part of the French version of the brief pain inventory (BPI) questionnaire. 0-10 scale. 10 indicating worst pain
At recruitment (baseline)
Pain severity
Time Frame: One month after injury
Pain level reported by the participant, as assessed via the first part of the French version of the brief pain inventory (BPI) questionnaire. 0-10 scale. 10 indicating worst pain
One month after injury
Pain severity
Time Frame: Three months after injury
Pain level reported by the participant, as assessed via the first part of the French version of the brief pain inventory (BPI) questionnaire. 0-10 scale. 10 indicating worst pain
Three months after injury
Pain severity
Time Frame: Six months after injury
Pain level reported by the participant, as assessed via the first part of the French version of the brief pain inventory (BPI) questionnaire. 0-10 scale. 10 indicating worst pain
Six months after injury
Pain severity
Time Frame: Twelve months after injury
Pain level reported by the participant, as assessed via the first part of the French version of the brief pain inventory (BPI) questionnaire. 0-10 scale. 10 indicating worst pain
Twelve months after injury
Anxiety and Depression.
Time Frame: At recruitment (baseline)
hospital anxiety and depression scale (HADS). Score 0-21. 21 = severe depression or anxiety
At recruitment (baseline)
Anxiety and Depression.
Time Frame: One month after injury
hospital anxiety and depression scale (HADS). Score 0-21. 21 = severe depression or anxiety
One month after injury
Anxiety and Depression.
Time Frame: Two months after injury
hospital anxiety and depression scale (HADS). Score 0-21. 21 = severe depression or anxiety
Two months after injury
Neuropathic pain
Time Frame: Two months after injury
The French questionnaire "Douleur Neuropathique en 4 Questions (DN4)" is completed by an investigator during follow-up visits. The DN4 questionnaire was developed to diagnose polyneuropathy. Three items are linked with neuropathic pain examination, and seven items to pain symptoms. Score 0-10. Score >4 indicates neuropathic pain.
Two months after injury
Neuropathic pain
Time Frame: Six months after injury
The French questionnaire "Douleur Neuropathique en 4 Questions (DN4)" is completed by an investigator during follow-up visits. The DN4 questionnaire was developed to diagnose polyneuropathy. Three items are linked with neuropathic pain examination, and seven items to pain symptoms. Score 0-10. Score >4 indicates neuropathic pain.
Six months after injury
Pain interference
Time Frame: At recruitment (baseline)
The last items of the BPI questionnaires measure how much pain has interfered with seven daily activities, including general activity, walking, work, mood, enjoyment of life, relations with others and sleep. BPI pain interference is scored as the mean of the seven items. Score 0-10. 10 = high interference of pain with activities.
At recruitment (baseline)
Pain interference
Time Frame: One month after injury
The last items of the BPI questionnaires measure how much pain has interfered with seven daily activities, including general activity, walking, work, mood, enjoyment of life, relations with others and sleep. BPI pain interference is scored as the mean of the seven items. Score 0-10. 10 = high interference of pain with activities.
One month after injury
Pain interference
Time Frame: Two months after injury
The last items of the BPI questionnaires measure how much pain has interfered with seven daily activities, including general activity, walking, work, mood, enjoyment of life, relations with others and sleep. BPI pain interference is scored as the mean of the seven items. Score 0-10. 10 = high interference of pain with activities.
Two months after injury
Pain interference
Time Frame: Three months after injury
The last items of the BPI questionnaires measure how much pain has interfered with seven daily activities, including general activity, walking, work, mood, enjoyment of life, relations with others and sleep. BPI pain interference is scored as the mean of the seven items. Score 0-10. 10 = high interference of pain with activities.
Three months after injury
Pain interference
Time Frame: Six months after injury
The last items of the BPI questionnaires measure how much pain has interfered with seven daily activities, including general activity, walking, work, mood, enjoyment of life, relations with others and sleep. BPI pain interference is scored as the mean of the seven items. Score 0-10. 10 = high interference of pain with activities.
Six months after injury
Pain interference
Time Frame: Twelve months after injury
The last items of the BPI questionnaires measure how much pain has interfered with seven daily activities, including general activity, walking, work, mood, enjoyment of life, relations with others and sleep. BPI pain interference is scored as the mean of the seven items. Score 0-10. 10 = high interference of pain with activities.
Twelve months after injury
Health and well being
Time Frame: At recruitment (baseline)
The 36-Item Health Survey (SF-36) taps eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. Score: 0-100. 100 = better functioning
At recruitment (baseline)
Health and well being
Time Frame: Two months after injury
The 36-Item Health Survey (SF-36) taps eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. Score: 0-100. 100 = better functioning
Two months after injury
Health and well being
Time Frame: Six months after injury
The 36-Item Health Survey (SF-36) taps eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions. Score: 0-100. 100 = better functioning
Six months after injury
Analgesic medication during hospitalisation
Time Frame: At recruitement (baseline)
During hospitalization, each day since the enrolment, amount and type of analgesic medication are recorded from the computerized patient record system.
At recruitement (baseline)
Analgesic medication at home
Time Frame: One month after injury
After discharge, analgesic medication (type and amount) is tracked using a custom questionnaire.
One month after injury
Analgesic medication at home
Time Frame: Two months after injury
After discharge, analgesic medication (type and amount) is tracked using a custom questionnaire.
Two months after injury
Analgesic medication at home
Time Frame: Three months after injury
After discharge, analgesic medication (type and amount) is tracked using a custom questionnaire.
Three months after injury
Analgesic medication at home
Time Frame: Six months after injury
After discharge, analgesic medication (type and amount) is tracked using a custom questionnaire.
Six months after injury
Analgesic medication at home
Time Frame: Twelve months after injury
After discharge, analgesic medication (type and amount) is tracked using a custom questionnaire.
Twelve months after injury
Productivity & return to work
Time Frame: One month after injury
The work productivity and activity impairment (WPAI) questionnaire is used. It assesses impairments in both paid work and unpaid work. It measures absenteeism, presenteeism as well as the impairments in unpaid activity because of health problem during the past seven days. Score 0-10. 10 = high impairment
One month after injury
Productivity & return to work
Time Frame: Two months after injury
The work productivity and activity impairment (WPAI) questionnaire is used. It assesses impairments in both paid work and unpaid work. It measures absenteeism, presenteeism as well as the impairments in unpaid activity because of health problem during the past seven days. Score 0-10. 10 = high impairment
Two months after injury
Productivity & return to work
Time Frame: Three months after injury
The work productivity and activity impairment (WPAI) questionnaire is used. It assesses impairments in both paid work and unpaid work. It measures absenteeism, presenteeism as well as the impairments in unpaid activity because of health problem during the past seven days. Score 0-10. 10 = high impairment
Three months after injury
Productivity & return to work
Time Frame: Six months after injury
The work productivity and activity impairment (WPAI) questionnaire is used. It assesses impairments in both paid work and unpaid work. It measures absenteeism, presenteeism as well as the impairments in unpaid activity because of health problem during the past seven days. Score 0-10. 10 = high impairment
Six months after injury
Productivity & return to work
Time Frame: Twelve months after injury
The work productivity and activity impairment (WPAI) questionnaire is used. It assesses impairments in both paid work and unpaid work. It measures absenteeism, presenteeism as well as the impairments in unpaid activity because of health problem during the past seven days. Score 0-10. 10 = high impairment
Twelve months after injury
Pulmonary function
Time Frame: Two months after injury
Forced vital capacity (FVC, % predicted) measured according to the recommendations of the European Respiratory Society. The best value of at least three tests is recorded.
Two months after injury
Pulmonary function, forced vital capacity
Time Frame: Six months after injury
Forced vital capacity (FVC, % predicted) measured according to the recommendations of the European Respiratory Society. The best value of at least three tests is recorded.
Six months after injury
Pulmonary function, peak expiratory flow
Time Frame: Two months after injury
Peak expiratory flow (PEF, L/min) measured according to the recommendations of the European Respiratory Society. The best value of at least three tests is recorded.
Two months after injury
Pulmonary function, peak expiratory flow
Time Frame: Six months after injury
Peak expiratory flow (PEF, L/min) measured according to the recommendations of the European Respiratory Society. The best value of at least three tests is recorded.
Six months after injury
Pulmonary function, sniff nasal inspiratory pressure
Time Frame: Two months after injury
sniff nasal inspiratory pressure (in in cmH2O) measured according to the recommendations of the European Respiratory Society. The best value of at least three tests is recorded.
Two months after injury
Pulmonary function, sniff nasal inspiratory pressure
Time Frame: Six months after injury
sniff nasal inspiratory pressure (in in cmH2O) measured according to the recommendations of the European Respiratory Society. The best value of at least three tests is recorded.
Six months after injury
Pulmonary function, inspiratory pressure
Time Frame: Two months after injury
Maximum inspiratory pressure (in in cmH2O) measured according to the recommendations of the European Respiratory Society. The best value of at least three tests is recorded.
Two months after injury
Pulmonary function, inspiratory pressure
Time Frame: Six months after injury
Maximum inspiratory pressure (in in cmH2O) measured according to the recommendations of the European Respiratory Society. The best value of at least three tests is recorded.
Six months after injury
Length of hospital stay
Time Frame: from admission to discharge, up to four weeks
Length of hospital stay is reported in days from the day of hospitalization until the hospital discharge. The length of convalescence stay is also reported.
from admission to discharge, up to four weeks
Total costs
Time Frame: Twelve months after injury
Costs are reported at the end of the follow-up period (12 months) in swiss francs. They include costs for hospital treatment and costs for medication.
Twelve months after injury
Adverse events
Time Frame: From inclusion to the end of the study, up to 12 months
We collect safety outcomes in accordance with international standards (ISO 14155 and ICH-GCP)
From inclusion to the end of the study, up to 12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Benoît Bédat, MD, University Hospital, Geneva
  • Study Chair: Frédéric Triponez, Prof., University Hospital, Geneva

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 12, 2021

Primary Completion (Actual)

November 16, 2023

Study Completion (Actual)

September 16, 2024

Study Registration Dates

First Submitted

December 6, 2020

First Submitted That Met QC Criteria

February 8, 2021

First Posted (Actual)

February 9, 2021

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 16, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2019-01688

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rib Fractures

Clinical Trials on Rib fixation

Subscribe